Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GLSI
GLSI logo

GLSI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Greenwich Lifesciences Inc (GLSI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
23.780
1 Day change
-1.45%
52 Week Range
34.100
Analysis Updated At
2026/05/01
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

GLSI is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The setup lacks strong bullish momentum, there are no recent news catalysts, no favorable proprietary trading signal, and the short-term pattern suggests weakness. Given the user's impatience and preference not to wait for a better entry, the direct call is to avoid buying now.

Technical Analysis

The technical picture is weak-to-neutral. MACD histogram is negative at -0.244, though it is contracting, which suggests bearish momentum is easing but not yet reversed. RSI_6 at 48.275 is neutral, showing no clear oversold buy signal. Moving averages are converging, indicating a possible decision point, but not a confirmed uptrend. Price at 23.72 is below the pivot of 25.17 and still inside the broader range between support at 21.728 and resistance at 28.612. The pattern-based forecast is negative, with a 60% chance of declines over the next day, week, and month.

Positive Catalysts

  • No recent news in the past week. AI Stock Picker: no signal on given stock today. SwingMax: no signal on given stock recently. Hedge funds and insiders are neutral, so there is no visible accumulation catalyst. Pre-market price is slightly green at 23.72 (+0.42%), but that is not enough to count as a meaningful bullish catalyst.

Neutral/Negative Catalysts

  • No news-driven catalyst is present. The stock trend model points to downside risk over the next day, week, and month. MACD remains below zero, and the stock is trading below its pivot. There is no favorable options sentiment available, no recent insider buying, and no recent hedge fund accumulation. Congress trading data shows no recent activity. The company also reported continued losses in Q3 2025, with net income at -4,151,845 and EPS at -0.3.

Financial Performance

In Q3 2025, GLSI showed no revenue growth because revenue remained at 0. Net income improved year over year by 55.57% to -4,151,845, and EPS improved 50.00% YoY to -0.3, but the company is still unprofitable. Gross margin remained at 0, so there is no evidence of operating revenue generation yet. For a beginner long-term investor, this financial profile is too weak to justify a new buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade trend to support a bullish case. Based on the available data, the Wall Street view appears weak: the pros are that losses are narrowing and technicals are not deeply oversold, but the cons are stronger, including no revenue, continued losses, no news catalysts, no insider or hedge fund support, and no favorable proprietary trading signal.

Wall Street analysts forecast GLSI stock price to rise
2 Analyst Rating
Wall Street analysts forecast GLSI stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 24.130
sliders
Low
45
Averages
47.5
High
50
Current: 24.130
sliders
Low
45
Averages
47.5
High
50
H.C. Wainwright
Buy
upgrade
$39 -> $50
AI Analysis
2025-12-30
Reason
H.C. Wainwright
Price Target
$39 -> $50
AI Analysis
2025-12-30
upgrade
Buy
Reason
H.C. Wainwright raised the firm's price target on Greenwich LifeSciences to $50 from $39 and keeps a Buy rating on the shares. The firm cites the positive efficacy in the non-HLA-A*02 arm of the ongoing Phase 3 FLAMINGO-01 trial of GLSI-100 in breast cancer for the target boost. GLSI-100 reduced breast cancer recurrence by 80% in the non- HLA-A*02 arm, the analyst tells investors in a research note. H.C. Wainwright views the preliminary data as "highly encouraging," saying it could double the market for GLSI-100.
Noble Capital
Outperform
initiated
$45
2025-08-20
Reason
Noble Capital
Price Target
$45
2025-08-20
initiated
Outperform
Reason
Noble Capital initiated coverage of Greenwich LifeSciences with an Outperform rating and $45 price target. Greenwich is developing GSLI-100, which has completed four clinical trials that lead to the design of the current Phase 3 Flamingo-01 trial for prevention of breast cancer recurrence in high-risk patients, the analyst tells investors. The firm, which estimates market entry by FY28, sees \"large market potential\" for GLSI-100.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GLSI
Unlock Now

People Also Watch